Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
4
×
new york top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
texas blog main
amgen
andrew bellinger
anish suri
arena pharmaceuticals
arvinas
biomarin pharmaceutical
cancer
cancer autoimmune diseases. peloton therapeutics
cardiovascular disease
cedilla therapeutics
cholesterol
colorectal cancer
What
medicine
4
×
drug
nobel
prize
aces
adapt
announced
ask
big
bio
cancer
cells
cellular
ceo
changes
cholesterol
congrats
effect
eisai
fda
flags
flexible
goes
higher
honored
icer’s
importance
incidence
inclisiran
isn't
key
known
led
levels
long
lorcaserin
loss
lowering
market
marketing
Language
unset
4
×
Current search:
unset
×
" new york blog main "
×
medicine
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
